post-bg-625
calendary June 28, 2022

Conditional and accelerated registration of drugs

In the previous article, we reviewed new registration procedures specific to certain drugs in accordance with the requirements of the EAEU. Currently, a drug be approved in the frame of approval procedure with post-registration obligations and in exceptional cases. In addition, Decision 36 also introduces conditional and accelerated registration, which will be discussed in this article.

1. Conditional registration (Section VII.II+Appendix 26).

This type of registration is suitable for drugs intended for the treatment, prevention, or diagnosis of serious (severe) disabling or life-threatening diseases. In this case, applicant can apply for registration before providing comprehensive clinical data. However, in this case, the benefits of earlier availability of the drug on the market should exceed the risk associated with the lack of comprehensive data. If there is an urgent need for such drugs, their registration can be carried out without providing comprehensive preclinical or biopharmaceutical data.

However, conditional registration requires the applicant to complete ongoing research or conduct new studies in order to confirm a positive benefit/risk ratio. The authorized body of a Member State may also determine other necessary conditions.

This procedure implies the validity of the registration certificate for 1 year and requires confirmation of registration (re-registration) with a reassessment of the ratio “benefit - risk” on an annual basis.

If all conditions are met, it is possible to issue a registration certificate for a period of 5 years with subsequent re-registration.

2. Accelerated registration (Section VII.IV+Appendix 27).

In this case, we are talking about an accelerated examination of the following drugs:

  • orphan;
  • intended exclusively for use by minors;
  • which are of particular importance for the health of the population, in particular, in the absence of effective methods of providing medical care.

The period for registration and examination of drugs in the reference state should not exceed 100 working days from the date of filing an application for registration of a drug until the day of issuance of the registration certificate.

To initiate an accelerated procedure, the applicant must send an application to the authorized body of the member state with strong justifications (it should be done before registration procedure).

The period for considering the application and informing the applicant is 40 working days.


  1. Materials of the SCIENTIFIC-PRACTICAL CONFERENCE “MODERN APPROACHES TO THE EXAMINATION AND REGISTRATION OF MEDICINES” REGLEK — 2022
  2. Decision of the Council of the Eurasian Economic Commission dated 03.11.2016 No. 78 (ed. 23.12.2020) “On the Rules of Registration and Expertise of Medicines for Medical Use”

 

References:

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE